Skip to main content
StrykerIn development

Stryker launches Sonopet® 3, delivering greater power and precision in ultrasonic tissue removal

Source: Autobound Signal API · 121 signals tracked for Stryker · updated

Get Stryker's live signals in Claude or ChatGPT, or by API

AskWhat changed at Stryker this week? Use Autobound signals for stryker.com.

What happened

Stryker announced Sonopet 3, its next-generation ultrasonic bone and soft tissue removal platform, which has received FDA 510(k) clearance ahead of anticipated clinical cases and commercial launch later this fall.

Source

Article excerpt

PORTAGE, Mich., Oct. 14, 2026 /PRNewswire/ -- Stryker (NYSE: SYK ), a global leader in medical technologies, announced today that Sonopet 3, its latest ultrasonic bone and soft tissue removal platform, has received 510(k) clearance from the U.S. Food and Drug Administration. Developed with input from hundreds of surgeons, Sonopet 3 is designed to deliver enhanced power, precision and versatility in a single platform for tissue removal. Surgeon collaboration directly shaped the new platform, informing key improvements in performance, workflow efficiency and clinical priorities. "At Stryker, innovation begins with listening to our customers," said Mitch Foley, vice president and general manager of Stryker's Neurosurgical business. "Every major advancement in Sonopet 3 can be attributed to surgeon feedback, and together we're elevating the standard in neurosurgery. They told us they wanted more power, improved ergonomics and enhanced integration, helping them perform with confidence in demanding surgical environments." In addition to performance enhancements, Sonopet 3 provides access to the platform's latest technologies, including RISE, a Reimagined Integrated Surgical Experience for a connected surgical workflow, and Pulse Control, which provides an added ability to regulate the resection of hard and soft tissues. Together, these advancements help support integration across...

Keep reading with a free account

The rest of this article, and every signal for Stryker, is in your free account.

Extracted from this sentence

The first clinical cases using Sonopet 3 are expected to begin in October, with a full commercial launch anticipated later this fall.

Extracted by Autobound

From the Signal API record
Event
In development

What this signalsWork in development often leads to new buying for tools, data and services.

Product
Sonopet 3
Location
Portage, Michigan, United States

The full record

From the Signal API record

Details

Release type
Generation
Ticker
NYSE:SYK

Topics and mentions

Product tags

  • general technology
  • medical

Extraction

Confidence
95%
Detected
Oct 14, 2026
signal_type
news
signal_subtype
is_developing

Use this data

Get every in development signal for Stryker and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Stryker this week?”

  2. Send it to your own tools

    The Signal API returns in development signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/54ef1d94-2cdb-9027-8e8a-f1bd8e184f06 returns this record as JSON. POST /v1/companies/enrich returns every signal for stryker.com.

{
  "signal_id": "54ef1d94-2cdb-9027-8e8a-f1bd8e184f06",
  "signal_type": "news",
  "signal_subtype": "is_developing",
  "detected_at": "2026-10-14T13:03:00+00:00",
  "company": {
    "name": "Stryker",
    "domain": "stryker.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/stryker-launches-sonopet-3-delivering-greater-power-and-precision-in-ultrasonic-tissue-removal-302907566.html",
    "title": "Stryker launches Sonopet® 3, delivering greater power and precision in ultrasonic tissue removal",
    "ticker": "NYSE:SYK",
    "excerpt": "PORTAGE, Mich. , Oct. 14, 2026 /PRNewswire/ -- Stryker (NYSE: SYK ), a global leader in medical technologies, announced today that Sonopet 3, its latest ultrasonic bone and soft tissue removal platform, has received 510(k) clearance from the U.S. Food and Drug Administration. Developed with input from hundreds of surgeons, Sonopet 3 is designed to deliver enhanced power, precision and versatility in a single platform for tissue removal. Surgeon collaboration directly shaped the new platform, informing key improvements in performance, workflow efficiency and clinical priorities. \"At Stryker, innovation begins with listening to our customers,\" said Mitch Foley, vice president and general manager of Stryker's Neurosurgical business. \"Every major advancement in Sonopet 3 can be attributed to surgeon feedback, and together we're elevating the standard in neurosurgery. They told us they wanted more power, improved ergonomics and enhanced integration, helping them perform with confidence in demanding surgical environments.\" In addition to performance enhancements, Sonopet 3 provides access to the platform's latest technologies, including RISE, a Reimagined Integrated Surgical Experience for a connected surgical workflow, and Pulse Control, which provides an added ability to regulate the resection of hard and soft tissues. Together, these advancements help support integration across...",
    "product": "Sonopet 3",
    "summary": "Stryker announced Sonopet 3, its next-generation ultrasonic bone and soft tissue removal platform, which has received FDA 510(k) clearance ahead of anticipated clinical cases and commercial launch later this fall.",
    "location": "Portage, Michigan, United States",
    "planning": true,
    "image_url": "https://mmx.prnewswire.com/media/MS2012570/Stryker-has-received-FDA-510.jpg?id=OA3016757&p=facebook",
    "confidence": 0.95,
    "product_data": {
      "name": "Sonopet 3",
      "full_text": "Sonopet 3, its latest ultrasonic bone and soft tissue removal platform",
      "fuzzy_match": false,
      "release_type": "generation"
    },
    "product_tags": [
      "general_technology",
      "medical"
    ],
    "published_at": "2026-10-14T13:03:00Z",
    "location_data": [
      {
        "city": "Portage",
        "state": "Michigan",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "The first clinical cases using Sonopet 3 are expected to begin in October, with a full commercial launch anticipated later this fall."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.